Apex Heart Hospital Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 5.00 M
as on 24-10-2024
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.00 Cr
as on 24-10-2024
- Revenue -23.42%
(FY 2023)
- Profit -21.85%
(FY 2023)
- Ebitda -32.20%
(FY 2023)
- Net Worth 10.34%
(FY 2023)
- Total Assets 10.41%
(FY 2023)
About Apex Heart Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹11.00 Cr.
Ravisankar and Sivasankar Sadasivam serve as directors at the Company.
- CIN/LLPIN
U74999TN2015PTC099368
- Company No.
099368
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Feb 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Thanjavur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Apex Heart Hospital?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravisankar  | Director | 25-Feb-2015 | Current |
| Sivasankar Sadasivam | Director | 25-Feb-2015 | Current |
Financial Performance of Apex Heart Hospital.
Apex Heart Hospital Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 23.42% decrease. The company also saw a substantial fall in profitability, with a 21.85% decrease in profit. The company's net worth Soared by an impressive increase of 10.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apex Heart Hospital?
In 2023, Apex Heart Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kasijagdha Agro Industries Private LimitedActive 3 years 11 monthsRavisankar and Sivasankar Sadasivam are mutual person
- Waloray Pharma Private LimitedActive 4 years 27 days
Ravisankar and Sivasankar Sadasivam are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 11 May 2023 | ₹11.00 Cr | Open |
How Many Employees Work at Apex Heart Hospital?
Apex Heart Hospital has a workforce of 31 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apex Heart Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Heart Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
